[1]
Shamburek RD, Schubert ML. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors. Gastroenterology clinics of North America. 1992 Sep:21(3):527-50
[PubMed PMID: 1355465]
[2]
Hall WM, Ratliff TB. Intensive care experience with intravenous cimetidine. Alabama medicine : journal of the Medical Association of the State of Alabama. 1990 Oct:60(4):22, 24, 26-8
[PubMed PMID: 2281832]
[3]
Das BB, Anton K, Soares N, Riojas S, Mcdermott J, Knox L, Daneman S, Puente BN. Cimetidine: A Safe Treatment Option for Cutaneous Warts in Pediatric Heart Transplant Recipients. Medical sciences (Basel, Switzerland). 2018 Apr 8:6(2):. doi: 10.3390/medsci6020030. Epub 2018 Apr 8
[PubMed PMID: 29642499]
[4]
Glass AT, Solomon BA. Cimetidine therapy for recalcitrant warts in adults. Archives of dermatology. 1996 Jun:132(6):680-2
[PubMed PMID: 8651718]
[5]
Jafarzadeh A, Nemati M, Khorramdelazad H, Hassan ZM. Immunomodulatory properties of cimetidine: Its therapeutic potentials for treatment of immune-related diseases. International immunopharmacology. 2019 May:70():156-166. doi: 10.1016/j.intimp.2019.02.026. Epub 2019 Feb 22
[PubMed PMID: 30802678]
[6]
Tu JH, Sheu SL, Teng JM. Novel Treatment Using Cimetidine for Erythropoietic Protoporphyria in Children. JAMA dermatology. 2016 Nov 1:152(11):1258-1261. doi: 10.1001/jamadermatol.2016.2303. Epub
[PubMed PMID: 27410690]
[7]
Fujimori N, Komatsu M, Tanaka N, Iwaya M, Nakano H, Sugiura A, Yamazaki T, Shibata S, Iwaya Y, Muraki T, Ichikawa Y, Kimura T, Joshita S, Umemura T, Matsumoto A, Tanaka E. Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury. Clinical journal of gastroenterology. 2017 Oct:10(5):452-458. doi: 10.1007/s12328-017-0760-1. Epub 2017 Jul 4
[PubMed PMID: 28676994]
[8]
Langendonk JG, Wilson JHP. Insufficient Evidence of Cimetidine Benefit in Protoporphyria. JAMA dermatology. 2017 Feb 1:153(2):237. doi: 10.1001/jamadermatol.2016.4049. Epub
[PubMed PMID: 30974454]
[9]
Teng JMC, Tu JH. Insufficient Evidence of Cimetidine Benefit in Protoporphyria-Reply. JAMA dermatology. 2017 Feb 1:153(2):238. doi: 10.1001/jamadermatol.2016.4050. Epub
[PubMed PMID: 30974455]
[10]
Franco I. Oral cimetidine for the management of genital and perigenital warts in children. The Journal of urology. 2000 Sep:164(3 Pt 2):1074-5
[PubMed PMID: 10958744]
[11]
Negro-Alvarez JM, Miralles-López JC. Chronic idiopathic urticaria treatment. Allergologia et immunopathologia. 2001 Jul-Aug:29(4):129-32
[PubMed PMID: 11674926]
[12]
Baker RA, Zeller RA, Klein RL, Thornton RJ, Shuber JH, Marshall RE, Leibfarth AG, Latko JA. Burn wound itch control using H1 and H2 antagonists. The Journal of burn care & rehabilitation. 2001 Jul-Aug:22(4):263-8
[PubMed PMID: 11482684]
[13]
Gaggiano C, Rigante D, Sota J, Grosso S, Cantarini L. Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review. Clinical rheumatology. 2019 Jan:38(1):11-17. doi: 10.1007/s10067-018-4361-2. Epub 2018 Nov 28
[PubMed PMID: 30488366]
Level 3 (low-level) evidence
[14]
Kokhaei P, Barough MS, Hassan ZM. Cimetidine effects on the immunosuppression induced by burn injury. International immunopharmacology. 2014 Sep:22(1):273-6. doi: 10.1016/j.intimp.2014.07.003. Epub 2014 Jul 16
[PubMed PMID: 25038319]
[15]
Jiang DW, Wang QR, Shen XR, He Y, Qian TT, Liu Q, Hou DY, Liu YM, Chen W, Ren X, Li KX. Radioprotective effects of cimetidine on rats irradiated by long-term, low-dose-rate neutrons and (60)Co γ-rays. Military Medical Research. 2017:4():7. doi: 10.1186/s40779-017-0116-7. Epub 2017 Feb 27
[PubMed PMID: 28261494]
[16]
Dasgupta P, Sharma SD, Womack C, Blackford HN, Dennis P. Cimetidine in painful bladder syndrome: a histopathological study. BJU international. 2001 Aug:88(3):183-6
[PubMed PMID: 11488726]
[17]
Kurbel S, Kurbel B. The role of gastric mast cells, enterochromaffin-like cells and parietal cells in the regulation of acid secretion. Medical hypotheses. 1995 Dec:45(6):539-42
[PubMed PMID: 8771047]
[18]
Wollin A. Regulation of gastric acid secretion at the cellular level. Clinical and investigative medicine. Medecine clinique et experimentale. 1987 May:10(3):209-14
[PubMed PMID: 2887322]
[19]
Schubert ML. Physiologic, pathophysiologic, and pharmacologic regulation of gastric acid secretion. Current opinion in gastroenterology. 2017 Nov:33(6):430-438. doi: 10.1097/MOG.0000000000000392. Epub
[PubMed PMID: 28787289]
[20]
Sabesin SM. Safety issues relating to long-term treatment with histamine H2-receptor antagonists. Alimentary pharmacology & therapeutics. 1993:7 Suppl 2():35-40
[PubMed PMID: 8103374]
[21]
Knigge UP. Histaminergic regulation of prolactin secretion. Danish medical bulletin. 1990 Apr:37(2):109-24
[PubMed PMID: 2188799]
[22]
Delle Fave GF, Tamburrano G, De Magistris L, Natoli C, Santoro ML, Carratu R, Torsoli A. Gynaecomastia with cimetidine. Lancet (London, England). 1977 Jun 18:1(8025):1319
[PubMed PMID: 68422]
[23]
Gibaldi M. Drug interactions: Part I. The Annals of pharmacotherapy. 1992 May:26(5):709-13
[PubMed PMID: 1591436]
Level 3 (low-level) evidence
[24]
O'Reilly RA. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man. Archives of internal medicine. 1984 May:144(5):989-91
[PubMed PMID: 6324710]
[25]
Feely J, Wilkinson GR, Wood AJ. Reduction of liver blood flow and propranolol metabolism by cimetidine. The New England journal of medicine. 1981 Mar 19:304(12):692-5
[PubMed PMID: 7464861]
[26]
Schwinghammer TL. Drug interactions with cimetidine. American journal of hospital pharmacy. 1981 Dec:38(12):1976-8
[PubMed PMID: 7325185]
[27]
Martínez C, Albet C, Agúndez JA, Herrero E, Carrillo JA, Márquez M, Benítez J, Ortiz JA. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists. Clinical pharmacology and therapeutics. 1999 Apr:65(4):369-76
[PubMed PMID: 10223772]
Level 2 (mid-level) evidence
[28]
Salom IL, Silvis SE, Doscherholmen A. Effect of cimetidine on the absorption of vitamin B12. Scandinavian journal of gastroenterology. 1982 Jan:17(1):129-31
[PubMed PMID: 7134827]
[29]
Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013 Dec 11:310(22):2435-42. doi: 10.1001/jama.2013.280490. Epub
[PubMed PMID: 24327038]
[30]
Larsson R, Erlanson P, Bodemar G, Walan A, Bertler A, Fransson L, Norlander B. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. British journal of clinical pharmacology. 1982 Feb:13(2):163-70
[PubMed PMID: 7059413]
Level 2 (mid-level) evidence
[31]
Delpre G, Kadish U, Livni E. Hepatitis following cimetidine administration. The American journal of the medical sciences. 1982 May-Jun:283(3):153-6
[PubMed PMID: 7081289]
[33]
Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Uziel E, Levy A. The safety of H(2)-blockers use during pregnancy. Journal of clinical pharmacology. 2010 Jan:50(1):81-7. doi: 10.1177/0091270009350483. Epub 2009 Sep 29
[PubMed PMID: 19789371]
[34]
van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, van der Cammen TJ, Stricker BH, Sturkenboom MC. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria--a population-based cohort study. British journal of clinical pharmacology. 2005 Aug:60(2):137-44
[PubMed PMID: 16042666]
[35]
Ruigómez A, García Rodríguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA, Johansson S. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. American journal of epidemiology. 1999 Sep 1:150(5):476-81
[PubMed PMID: 10472947]